
Biotech Behemoth or Bumpy Ride? CSL’s Stock in the Tech Era
CSL Limited is at the forefront of the biotech industry’s transformation, driven by AI and genomics. AI integration accelerates drug discovery and enhances treatment accuracy, potentially increasing CSL’s market position. Genomics offers opportunities for personalized medicine, providing competitive advantages for CSL. Investments